Literature DB >> 29303154

A novel and less invasive technique to assess cytokine profile of vitreous in patients of diabetic macular oedema.

G Srividya1, M Jain2, K Mahalakshmi3, S Gayathri2, R Raman2, N Angayarkanni1.   

Abstract

PurposeA pilot study to validate the collection of vitreous reflux (VR) after intravitreal injection using Schirmers tear strips was carried out. We assessed its efficiency for proteomics studies by estimating the differential expression of 27 cytokines using multiplexed bead array in diabetic macular oedema and proliferative diabetic retinopathy. To set, validate and assess the efficacy of Schirmer tear strips for collecting VR in patients undergoing intravitreal injections for diabetic macular oedema (DME).Patients and methodsVR samples were collected from 11 eyes of DME patients after intravitreal injections using Schirmer tear strips. Undiluted vitrectomy samples were obtained from six eyes of non-diabetic patients with idiopathic macular hole and seven eyes of diabetic patients with high-risk proliferative diabetic retinopathy (Hr-PDR), which were also subsampled on the Schirmer tear strips. Tear sampling was done in a subset of the DME patients. Total protein concentration between VR and vitrectomy samples was compared. Levels of the set of 27 cytokines in Schirmer tear strips samples were measured. Inter-group comparison for cytokines was done using Mann-Whitney U-test.ResultsSimilar protein concentration in VR samples and vitrectomy samples (P<0.05) was obtained. Tear protein contamination was not detected in VR samples. In comparison with no-DR patients, 25 and 20 of the measured 27 cytokines were significantly elevated (P<0.05) in the Hr-PDR and DME patients, respectively. As compared with no-DR patients, vascular endothelial growth factor was only moderately elevated in DME patients (P>0.05), but significantly elevated in Hr-PDR patients (P<0.05). Interleukin 1 receptor antagonist/interleukin 1b (IL1RA/IL1b) ratio was 13 times higher in DME patients as compared with Hr-PDR group.ConclusionWe demonstrated a simple, safe method of VR sampling. This technique provides a pure, albeit small, vitreous sample for proteomics. IL1RA/IL1b ratio was found to be 13-fold higher in the DME group as compared to the Hr-PDR.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29303154      PMCID: PMC5898864          DOI: 10.1038/eye.2017.285

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  50 in total

1.  Is diabetic retinopathy an inflammatory disease?

Authors:  A P Adamis
Journal:  Br J Ophthalmol       Date:  2002-04       Impact factor: 4.638

2.  Role of intravitreal inflammatory cytokines and angiogenic factors in proliferative diabetic retinopathy.

Authors:  Jinzi Zhou; Shuhong Wang; Xiaobo Xia
Journal:  Curr Eye Res       Date:  2012-03-12       Impact factor: 2.424

3.  Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease.

Authors:  Ponnalagu Murugeswari; Dhananjay Shukla; Anand Rajendran; Ramasamy Kim; Perumalsamy Namperumalsamy; Veerappan Muthukkaruppan
Journal:  Retina       Date:  2008-06       Impact factor: 4.256

4.  A Simple Spontaneous Vitreal Reflux Collecting Procedure During Intravitreal Injection: Set-Up and Validation Studies.

Authors:  Andrea Cacciamani; Mariacristina Parravano; Fabio Scarinci; Graziana Esposito; Monica Varano; Alessandra Micera
Journal:  Curr Eye Res       Date:  2015-10-15       Impact factor: 2.424

5.  L-arginine transport in retinas from streptozotocin diabetic rats: correlation with the level of IL-1 beta and NO synthase activity.

Authors:  A Carmo; J G Cunha-Vaz; A P Carvalho; M C Lopes
Journal:  Vision Res       Date:  1999-11       Impact factor: 1.886

6.  Two dimensional electrophoretic analysis of human tears: collection method in dry eye syndrome.

Authors:  Aluru Venkata Saijyothi; Narayanasamy Angayarkanni; Chandran Syama; Tatu Utpal; Agarwal Shweta; Srinivasan Bhaskar; Iyer Krishnan Geetha; Pillai S Vinay; Maruthamuthu Thennarasu; Rajappa M Sivakumar; Padmanabhan Prema
Journal:  Electrophoresis       Date:  2010-10       Impact factor: 3.535

7.  Dexamethasone Intravitreal Implant for Chronic Diabetic Macular Edema Resistant to Intravitreal Bevacizumab Treatment.

Authors:  Yüksel Totan; Emre Güler; Fatma Betül Gürağaç
Journal:  Curr Eye Res       Date:  2015-01-22       Impact factor: 2.424

8.  Profiling of vitreous proteomes from proliferative diabetic retinopathy and nondiabetic patients.

Authors:  Taeoh Kim; Sang Jin Kim; Kyunggon Kim; Un-Beom Kang; Cheolju Lee; Kyong Soo Park; Hyeong Gon Yu; Youngsoo Kim
Journal:  Proteomics       Date:  2007-11       Impact factor: 3.984

9.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

Authors:  L P Aiello; R L Avery; P G Arrigg; B A Keyt; H D Jampel; S T Shah; L R Pasquale; H Thieme; M A Iwamoto; J E Park
Journal:  N Engl J Med       Date:  1994-12-01       Impact factor: 91.245

10.  Proteomic analysis of human vitreous humor.

Authors:  Krishna R Murthy; Renu Goel; Yashwanth Subbannayya; Harrys Kc Jacob; Praveen R Murthy; Srikanth Srinivas Manda; Arun H Patil; Rakesh Sharma; Nandini A Sahasrabuddhe; Arun Parashar; Bipin G Nair; Venkatarangaiah Krishna; Ts Keshava Prasad; Harsha Gowda; Akhilesh Pandey
Journal:  Clin Proteomics       Date:  2014-07-14       Impact factor: 3.988

View more
  10 in total

Review 1.  [Unmet research and developmental needs in ophthalmology : A consensus-based road map of the European Vision Institute for 2019-2025].

Authors:  C Cursiefen; F Cordeiro; J Cunha-Vaz; T Wheeler-Schilling; H P N Scholl
Journal:  Ophthalmologe       Date:  2019-09       Impact factor: 1.059

2.  Effect of Humanin G (HNG) on inflammation in age-related macular degeneration (AMD).

Authors:  Sonali Nashine; Pinchas Cohen; Junxiang Wan; M Cristina Kenney
Journal:  Aging (Albany NY)       Date:  2022-05-16       Impact factor: 5.955

Review 3.  Anti-VEGF-Resistant Retinal Diseases: A Review of the Latest Treatment Options.

Authors:  Josh O Wallsh; Ron P Gallemore
Journal:  Cells       Date:  2021-04-29       Impact factor: 6.600

Review 4.  The Vitreous Ecosystem in Diabetic Retinopathy: Insight into the Patho-Mechanisms of Disease.

Authors:  Siva S R Iyer; Mollie K Lagrew; Stephanie M Tillit; Ramak Roohipourmoallai; Samuel Korntner
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

Review 5.  Proteomic Biomarkers of Retinal Inflammation in Diabetic Retinopathy.

Authors:  Hannah Youngblood; Rebekah Robinson; Ashok Sharma; Shruti Sharma
Journal:  Int J Mol Sci       Date:  2019-09-25       Impact factor: 5.923

6.  The role of IL-6-174 G/C polymorphism and intraocular IL-6 levels in the pathogenesis of ocular diseases: a systematic review and meta-analysis.

Authors:  Zulvikar Syambani Ulhaq; Gita Vita Soraya; Lely Retno Wulandari
Journal:  Sci Rep       Date:  2020-10-15       Impact factor: 4.379

7.  Interleukin-6 Trans-signaling: A Pathway With Therapeutic Potential for Diabetic Retinopathy.

Authors:  Shruti Sharma
Journal:  Front Physiol       Date:  2021-05-19       Impact factor: 4.566

Review 8.  Inflammatory and angiogenic biomarkers in diabetic retinopathy.

Authors:  Snježana Kaštelan; Ivana Orešković; Filip Bišćan; Helena Kaštelan; Antonela Gverović Antunica
Journal:  Biochem Med (Zagreb)       Date:  2020-08-05       Impact factor: 2.313

Review 9.  IL-1 Family Members Mediate Cell Death, Inflammation and Angiogenesis in Retinal Degenerative Diseases.

Authors:  Yvette Wooff; Si Ming Man; Riemke Aggio-Bruce; Riccardo Natoli; Nilisha Fernando
Journal:  Front Immunol       Date:  2019-07-16       Impact factor: 7.561

Review 10.  Vitreous Humor Proteome: Targeting Oxidative Stress, Inflammation, and Neurodegeneration in Vitreoretinal Diseases.

Authors:  Fátima Milhano Santos; Joana Mesquita; João Paulo Castro-de-Sousa; Sergio Ciordia; Alberto Paradela; Cândida Teixeira Tomaz
Journal:  Antioxidants (Basel)       Date:  2022-03-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.